A novel sensitive and selective electrochemical sensor based on integration of molecularly imprinted with hollow silver nanospheres for determination of carbamazepine

A ratiometric electrochemical sensor for antiepileptic drug of carbamazepine based on electroactive Ni2+-terephthalic acid MOF

Carbamazepine (CBZ), an anticonvulsant and mood stabilizer used extensively for epilepsy, requires a reliable and sensitive monitoring assay for assessing and optimizing the dosage administered to epileptic patients. In this work, spherical nickel-based metal-organic framework materials (Ni-MOFs) consisting of nanosheets were synthesized and cast on glassy carbon electrode (GCE) to prepare a novel ratiometric CBZ electrochemical sensor. The electrochemical test results showed that the Ni-MOF-based sensor had a pair of reversible redox peaks at +0.54 V and +0.39 V, respectively, originating from the Ni3+/Ni2+ pair. Meanwhile, CBZ presented an intense irreversible oxidation peak at +1.22 V on the sensor, and its peak current intensity was significantly higher than that on bare GCE and Nafion/GCE. This enhancement can be ascribed to the synergistic effects of the extensive electroactive surface area and the superior electron transfer kinetics of the Ni-MOF, as evidenced by comprehensive physical and electrochemical characterizations. Further, ratiometric sensing detection of CBZ can be achieved by measuring the ratio (R) of oxidation peak currents between CBZ and Ni-MOF, using the Ni-MOF's oxidation peak as the internal reference signal. Under the optimal experimental conditions, the sensor can detect CBZ in the concentration range from 20 to 300 μM with the detection limit as low as 1.03 μM. The recoveries of 94.2-103.3 % were obtained when the sensor was used for the determination of CBZ in serum samples, which demonstrated that the sensor has potential applications in the monitoring of CBZ residues in biological samples.

Disposable Sensor Chips with Molecularly Imprinted Carbon Paste Electrodes for Monitoring Anti-Epileptic Drugs

Epilepsy is a neurological disorder that affects millions of people worldwide. Anti-epileptic drugs (AEDs) are critical for their management. However, the therapeutic window is narrow, and traditional laboratory-based therapeutic drug monitoring (TDM) methods can be time consuming and unsuitable for point-of-care testing. To address this issue, we developed a disposable sensor chip based on molecularly imprinted polymer-modified carbon paste electrodes (MIP-CPs) for the TDM of AEDs such as phenobarbital (PB), carbamazepine (CBZ), and levetiracetam (LEV). In this work, functional monomers (methacrylic acid) and crosslinking monomers (methylene bisacrylamide and ethylene glycol dimethacrylate) were copolymerized in the presence of the AED template and grafted on the graphite particles by simple radical photopolymerization. The grafted particles were mixed with silicon oil, dissolving ferrocene as a redox marker to make the MIP-carbon paste (CP). Disposable sensor chips were fabricated by packing the MIP-CP into the base made of poly (ethylene glycol terephthalate) (PET) film. The sensor's sensitivity was determined using differential pulse voltammetry (DPV), carried out on a single sensor chip for each operation. Linearity was obtained from 0-60 μg/mL in PB and LEV and 0-12 μg/mL in CBZ, covering their respective therapeutic range. The time taken for each measurement was around 2 min. The experiment using whole bovine blood and bovine plasma indicated that the existence of species that interfered had a negligible effect on the test's sensitivity. This disposable MIP sensor provides a promising approach for point-of-care testing and facilitating the management of epilepsy. Compared with existing tests, this sensor offers a faster and more accurate way to monitor AEDs, which is crucial for optimizing therapy and improving patient outcomes. Overall, the proposed disposable sensor chip based on MIP-CPs represents a significant advancement in AED monitoring, with the potential for rapid, accurate, and convenient point-of-care testing.

Ultrasensitive electrochemical sensor for the detection of carbamazepine based on gadolinium vanadate nanostructure decorated functionalized carbon nanofiber nanocomposite

The gadolinium vanadate nanostructure decorated functionalized carbon nanofiber (GdVO₄/f-CNF) nanocomposite was prepared by the hydrothermal method, which is fabricated on a glassy carbon electrode (GCE) for the determination of carbamazepine (CBZ). The structural morphology of the hydrothermally synthesized GdVO₄/f-CNF material was investigated by several spectroscopy methods such as FESEM, HRTEM, EDS-mapping, XRD, XPS, and Raman. Moreover, the electrical conductivity of our synthesized material was inspected by the electrochemical impedance spectroscopy (EIS) analysis, and the electrochemical performance towards CBZ was inspected by the cyclic voltammetry (CV) and amperometry (AMP) analysis under optimized conditions. The AMP determination of CBZ exhibits the lowest level LOD of 0.0018 μM and a good linear range of 0.01-157 μM. Additionally, our proposed sensor was used to determine the CBZ in the pharmaceutical and, human urine samples which have exposed the acceptable recoveries.

Electrochemical Carbamazepine Aptasensor for Therapeutic Drug Monitoring at the Point of Care

Monitoring the anti-epileptic drug carbamazepine (CBZ) is crucial for proper dosing, optimizing a patient's clinical outcome, and managing their medication regimen. Due to its narrow therapeutic window and concentration-related toxicity, CBZ is prescribed and monitored in a highly personalized manner. We report an electrochemical conformation-changing aptasensor with two assay formats: a 30 min assay for routine monitoring and a 5 min assay for rapid emergency testing. To enable "sample-to-answer" testing, a de novo CBZ aptamer (K _d < 12 nM) with conformational switching due to a G-quadruplex motif was labeled with methylene blue and immobilized on a gold electrode. The electrode fabrication and detection conditions were optimized using electrochemical techniques and visualized by atomic force microscopy (AFM). The aptasensor performance, including reproducibility, stability, and interference, was characterized using electrochemical impedance spectroscopy and voltammetry techniques. The aptasensor exhibited a wide dynamic range in buffer (10 nM to 100 μM) with limits of detection of 1.25 and 1.82 nM for the 5 and 30 min assays, respectively. The clinical applicability is demonstrated by detecting CBZ in finger prick blood samples (<50 μL). The proposed assays provide a promising method to enable point-of-care monitoring for timely personalized CBZ dosing.

Wearable Sensor for Continuous Sweat Biomarker Monitoring

In recent years, wearable sensors have enabled the unique mode of real-time and noninvasive monitoring to develop rapidly in medical care, sports, and other fields. Sweat contains a wide range of biomarkers such as metabolites, electrolytes, and various hormones. Combined with wearable technology, sweat can reflect human fatigue, disease, mental stress, dehydration, and so on. This paper comprehensively describes the analysis of sweat components such as glucose, lactic acid, electrolytes, pH, cortisol, vitamins, ethanol, and drugs by wearable sensing technology, and the application of sweat wearable devices in glasses, patches, fabrics, tattoos, and paper. The development trend of sweat wearable devices is prospected. It is believed that if the sweat collection, air permeability, biocompatibility, sensing array construction, continuous monitoring, self-healing technology, power consumption, real-time data transmission, specific recognition, and other problems of the wearable sweat sensor are solved, we can provide the wearer with important information about their health level in the true sense.

Sensitive and selective detection of carbamazepine in serum samples by bionic double-antibody sandwich method based on cucurbit[7]uril and molecular imprinted polymers

A novel bionic enzyme-linked immunosorbent assay (BELISA) based on double-antibody sandwich method is firstly designed for the detection of carbamazepine (CBZ) in human serum samples. In this BELISA system, cucurbit[7]uril (CB[7]) is employed as an artificial capture antibody (cAb), and molecularly imprinted polymers (MIPs) is used as an artificial detection antibody (dAb). Nanozymes (PdNPs) as signal generators are integrated with MIPs. This couple of bionic antibodies exhibits not only the excellent physical and chemical stability, but also the superior molecular recognition ability. Based on two bionic antibodies that can selectively recognize different sites of CBZ molecule, a new BELISA method has been constructed for the first time. The proposed BELISA method displays a good linear relationship ranging from 2 to 20 μg mL^-1. The detection limit is 0.37 μg mL^-1, which can well meet clinical testing demand. It provides a more stable and economical method for clinical therapeutic drug monitoring (TDM).

Application of a thermo-sensitive imprinted SERS substrate to the rapid trace detection of ofloxacin

A novel composite (AgNPs-MIPs) was prepared by combining nano-silver particles with an ofloxacin (OFL) imprinted thermo-sensitive hydrogel. The thermo-sensitive optical properties of the composite were studied and it was used as a Raman substrate for the detection of ofloxacin. The results have shown that the position and intensity of the plasmon resonance absorption peak of the AgNPs-MIPs can be reversibly changed with the change of temperature, and the intensity of the ofloxacin Raman signal increases with the increase of temperature. Because the hydrogel combined Raman enhancement of silver nanoparticles, the selectivity of molecularly imprinted materials and the intelligent response of thermo-sensitive hydrogels, it can realize rapid, in situ, trace and selective detection of ofloxacin. Moreover, the detection limit can reach 10^-10 mol L^-1.

Novel electrochemical sensing platform based on ion imprinted polymer with nanoporous gold for ultrasensitive and selective determination of As3

An electrochemical sensor has been developed based on ion imprinted polymer (IIP) and nanoporous gold (NPG) modified gold electrode (IIP/NPG/GE) for determination of arsenic ion (As³⁺) in different kinds of water. NPG with high conductivity, large specific surface area, and high biocompatibility was prepared by a green electrodeposition method. Then a layer of IIP was synthesized in situ on NPG surface by electropolymerization, in which As³⁺ was used as template ion and o-phenylenediamine as functional monomer. We used potassium ferricyanide and potassium ferrocyanide chelates as electrochemical probes to generate signals. The electrochemical behavior of IIP/NPG/GE (vs. Ag/AgCl) was studied by cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). The linear range for As³⁺ was 2.0 × 10^-11 to 9.0 × 10^-9 M, and the lower detection limit was 7.1 × 10^-12 M (S/N = 3). This newly developed sensor has good stability and selectivity, and has been successfully applied to the As³⁺ determination of four kinds of water quality.

Two-Dimensional Metallic NiSe2 Nanoclusters-Based Low-Cost, Flexible, Amperometric Sensor for Detection of Neurological Drug Carbamazepine in Human Sweat Samples

Here we report a low-cost, flexible amperometric sensing platform for highly selective and sensitive detection of carbamazepine (CBZ) in human sweat samples. Detailed morphological characterization of the two-dimensional transition metal dichalcogenide NiSe₂, synthesized using one-step hydrothermal method, confirms the formation of dense NiSe₂ nanoclusters in the range of 500–650 nm, whereas X-ray diffraction and X-ray photoelectron spectroscopy studies reveal a stable and pure cubic crystalline phase of NiSe₂. The sensor device is fabricated by uniformly depositing an optimized weight percentage of as-synthesized NiSe₂ onto flexible and biocompatible polyimide substrate using spin coating, and metal contacts are established using thermal evaporation technique. The sensor exhibits a remarkable sensitivity of 65.65 μA/nM over a wide linear range of 50 nM to 10 μM CBZ concentrations and a low limit of detection of 18.2 nM. The sensing mechanism and excellent response of NiSe₂ toward CBZ can be attributed to the highly conductive metallic NiSe₂, large electroactive surface area of its nanoclusters, and highly interactive Ni²⁺/Ni³⁺ oxidation states. Furthermore, the presence of 10-fold excess of capable interferents, such as lactic acid, glucose, uric acid, and ascorbic acid, does not affect the accurate determination of CBZ, thus demonstrating excellent selectivity. The real-time detection of CBZ is evaluated in human sweat samples using standard addition method, which yields reliable results. Furthermore, the sensor shows excellent robustness when subject to bending cycles and fast response time of 2 s. The strategy outlined here is useful in developing sensing platforms at low potential without the use of enzymes or redox binders for applications in healthcare.

How Reliable Is the Electrochemical Readout of MIP Sensors?

Electrochemical methods offer the simple characterization of the synthesis of molecularly imprinted polymers (MIPs) and the readouts of target binding. The binding of electroinactive analytes can be detected indirectly by their modulating effect on the diffusional permeability of a redox marker through thin MIP films. However, this process generates an overall signal, which may include nonspecific interactions with the nonimprinted surface and adsorption at the electrode surface in addition to (specific) binding to the cavities. Redox-active low-molecular-weight targets and metalloproteins enable a more specific direct quantification of their binding to MIPs by measuring the faradaic current. The in situ characterization of enzymes, MIP-based mimics of redox enzymes or enzyme-labeled targets, is based on the indication of an electroactive product. This approach allows the determination of both the activity of the bio(mimetic) catalyst and of the substrate concentration.